Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Halpin

Showing results (171-180 of 197) with videos related to

Pageof 20
Sort By:
American Journal of Respiratory and Critical Care Medicine|June 6, 2024
Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic DiseasesWassim W Labaki, Alvar Agusti, Surya P Bhatt, et al.
Respiratory Research|September 11, 2024
Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge SummaryWenying Lu, Rebekka Aarsand, Kerstin Schotte, et al.
Respiratory Medicine|December 5, 2022
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysisSamuel Bardsley, Gerard J Criner, David M G Halpin, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 18, 2021
Discordant diagnostic criteria for pneumonia in COPD trials: a reviewRobert A Wise, Mona Bafadhel, Courtney Crim, et al.
The European Respiratory Journal|August 13, 2021
A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trialMona Bafadhel, Neil Barnes, Stephen C Bourke, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 30, 2022
Key messages and partnerships to raise awareness and improve outcomes for people with asthma and COPD in low- and middle-income countriesS Rylance, E D Bateman, L Boulet, et al.
The New England Journal of Medicine|April 19, 2018
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPDDavid A Lipson, Frank Barnhart, Noushin Brealey, et al.
The Lancet. Respiratory Medicine|July 9, 2019
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trialSteven Pascoe, Neil Barnes, Guy Brusselle, et al.
American Journal of Respiratory and Critical Care Medicine|February 15, 2024
Early Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease: The Costs and Benefits of Case FindingShawn D Aaron, Maria Montes de Oca, Bartolome Celli, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2020
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary DiseaseDavid A Lipson, Courtney Crim, Gerard J Criner, et al.
Pageof 20

Showing results (171-180 of 197) with videos related to

Sort By:
Pageof 20
American Journal of Respiratory and Critical Care Medicine|June 6, 2024
Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic DiseasesWassim W Labaki, Alvar Agusti, Surya P Bhatt, et al.
Respiratory Research|September 11, 2024
Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge SummaryWenying Lu, Rebekka Aarsand, Kerstin Schotte, et al.
Respiratory Medicine|December 5, 2022
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysisSamuel Bardsley, Gerard J Criner, David M G Halpin, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 18, 2021
Discordant diagnostic criteria for pneumonia in COPD trials: a reviewRobert A Wise, Mona Bafadhel, Courtney Crim, et al.
The European Respiratory Journal|August 13, 2021
A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trialMona Bafadhel, Neil Barnes, Stephen C Bourke, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 30, 2022
Key messages and partnerships to raise awareness and improve outcomes for people with asthma and COPD in low- and middle-income countriesS Rylance, E D Bateman, L Boulet, et al.
The New England Journal of Medicine|April 19, 2018
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPDDavid A Lipson, Frank Barnhart, Noushin Brealey, et al.
The Lancet. Respiratory Medicine|July 9, 2019
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trialSteven Pascoe, Neil Barnes, Guy Brusselle, et al.
American Journal of Respiratory and Critical Care Medicine|February 15, 2024
Early Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease: The Costs and Benefits of Case FindingShawn D Aaron, Maria Montes de Oca, Bartolome Celli, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2020
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary DiseaseDavid A Lipson, Courtney Crim, Gerard J Criner, et al.
Pageof 20